Drugs / norethisterone enantate
norethisterone enantate
also known as
17alpha-ethinyl-17beta-heptanoyloxy-4-estrene-3-one · Net-En · norethisterone enanthate · Noristerat
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02170038 | Jun → Dec 2014 | — | Bayer | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02905890 | Oct 2017 → Dec 2019 | HIV infectious disease, bacterial vaginosis | London School of Hygiene and Tropical Medicine | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02404038 Comparator | Jul 2015 → Jul 2017 | HIV infectious disease | Desmond Tutu HIV Centre | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norethisterone enantate | “Subjects will receive one intramuscular dose of Noristerat (oily solution for intramuscular injection) containing 200 mg norethisterone enantate.” NCT02170038 ↗2“Each ampoule of Nur-Isterate contains 1ml/200mg of norethisterone enantate (17alpha-ethinyl-17beta-heptanoyloxy-4-estrene-3-one).” NCT02404038 ↗ |
| Known as | 17alpha-ethinyl-17beta-heptanoyloxy-4-estrene-3-one | “Each ampoule of Nur-Isterate contains 1ml/200mg of norethisterone enantate (17alpha-ethinyl-17beta-heptanoyloxy-4-estrene-3-one).” NCT02404038 ↗ |
| Known as | Net-En | “injectable norethisterone enanthate (Net-En), an etonorgesterol/ethinyl estradiol vaginal ring (NuvaRing), or oral contraceptives in the UChoose trial (NCT02404038) at baseline...” PMID 35348351 ↗ Mar 2022 |
| Known as | norethisterone enanthate | “injectable norethisterone enanthate (Net-En), an etonorgesterol/ethinyl estradiol vaginal ring (NuvaRing), or oral contraceptives in the UChoose trial (NCT02404038) at baseline...” PMID 35348351 ↗ Mar 2022 |
| Known as | Noristerat | “Subjects will receive one intramuscular dose of Noristerat (oily solution for intramuscular injection) containing 200 mg norethisterone enantate.” NCT02170038 ↗ |
| Route | Intramuscular | “solution for intramuscular injection given every 8 weeks” NCT02905890 ↗ |